{"id":1027,"date":"2020-01-30T05:58:37","date_gmt":"2020-01-30T05:58:37","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=1027"},"modified":"2020-01-30T05:58:37","modified_gmt":"2020-01-30T05:58:37","slug":"bisphosphonate-bp-syn","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/","title":{"rendered":"Bisphosphonate (BP) (syn)"},"content":{"rendered":"

Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.  <\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1027","post","type-post","status-publish","format-standard","hentry","category-b"],"yoast_head":"\nBisphosphonate (BP) (syn) - Definition of Bisphosphonate (BP) (syn)<\/title>\n<meta name=\"description\" content=\"Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bisphosphonate (BP) (syn) - Definition of Bisphosphonate (BP) (syn)\" \/>\n<meta property=\"og:description\" content=\"Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-30T05:58:37+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/\",\"name\":\"Bisphosphonate (BP) (syn) - Definition of Bisphosphonate (BP) (syn)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-01-30T05:58:37+00:00\",\"dateModified\":\"2020-01-30T05:58:37+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bisphosphonate (BP) (syn)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bisphosphonate (BP) (syn) - Definition of Bisphosphonate (BP) (syn)","description":"Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/","og_locale":"en_US","og_type":"article","og_title":"Bisphosphonate (BP) (syn) - Definition of Bisphosphonate (BP) (syn)","og_description":"Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/","og_site_name":"Glossary","article_published_time":"2020-01-30T05:58:37+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/","name":"Bisphosphonate (BP) (syn) - Definition of Bisphosphonate (BP) (syn)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-01-30T05:58:37+00:00","dateModified":"2020-01-30T05:58:37+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Diphosphonate. Group of drugs used to manage osteoporosis and Paget\u2019s disease, or to treat hypercalcemia of malignancy or metastatic bone lesions. Its mechanism of action involves the suppression of osteoclasts, thereby reducing bone resorption. Two main groups exist: nitrogen containing and nonnitrogen containing, with subgroups of either oral or intravenous administration.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/bisphosphonate-bp-syn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Bisphosphonate (BP) (syn)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/1027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=1027"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/1027\/revisions"}],"predecessor-version":[{"id":1028,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/1027\/revisions\/1028"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=1027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=1027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=1027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}